EMPA-REG OUTCOME

Welcome to the Brand page for “EMPA-REG OUTCOME”, which is offered here for Publication of printed matter with the results of clinical studies concerning pharmaceutical preparations;the mark consists of the wording empa-reg in capitalized gray letters slightly larger and above the word outcome also in gray capital letters. to the left of the wording is an abstract design comprised of several circles of various sizes forming a ring with an irregular circumference, with the circles in the colors red, blue, gray and violet.;the color(s) red (pms 1925), blue (pms 279), grey (pms 424), and violet (pms 527) is/are claimed as a feature of the mark.;outcome;medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “EMPA-REG OUTCOME” is believed to be currently owned by “Boehringer Ingelheim International GmbH”.

Owner:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Owner Details
Description:
Publication of printed matter with the results of clinical studies concerning pharmaceutical preparations;The mark consists of the wording EMPA-REG in capitalized gray letters slightly larger and above the word OUTCOME also in gray capital letters. To the left of the wording is an abstract design comprised of several circles of various sizes forming a ring with an irregular circumference, with the circles in the colors red, blue, gray and violet.;The color(s) red (pms 1925), blue (pms 279), grey (pms 424), and violet (pms 527) is/are claimed as a feature of the mark.;OUTCOME;Medical and scientific research in the field of diabetes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
Categories: PUBLICATION PRINTED MATTER WITH